Transgenic mouse models generated by hydrodynamic transfection for genetic studies of liver cancer and preclinical testing of anti‐cancer therapy
Open Access
- 28 July 2015
- journal article
- review article
- Published by Wiley in International Journal of Cancer
- Vol. 138 (7) , 1601-1608
Abstract
Hepatocellular carcinoma (HCC) is one of the most lethal cancers worldwide; however, the genetic mechanisms underlying its pathogenesis are incompletely understood. Genetically engineered mouse (GEM) models of HCC have been developed to elucidate the role of individual cancer‐related genes in hepatocarcinogenesis. However, the expensive and time‐consuming processes related to generating a GEM model discourage the development of diverse genotype models. Recently, a simple and inexpensive liver‐specific transgenic approach was developed, in which a hydrodynamics‐based transfection (HT) method was coupled with the Sleeping Beauty transposase system. Various HT models in which different oncogenic pathways are activated and/or tumor‐suppressing pathways inactivated have been developed in recent years. The applicability of HT models in liver cancer research is expected to broaden and ultimately elucidate the cooperation between oncogenic signaling pathways and aid in designing molecular therapy to target altered pathways.Keywords
Funding Information
- Ministry of Education (Basic Science Research Program through the National Research Foundation of Korea) (NRF-2011-0021830 (to S.W.R.))
This publication has 100 references indexed in Scilit:
- MYC on the Path to CancerCell, 2012
- AKT (v-akt murine thymoma viral oncogene homolog 1) and N-Ras (neuroblastoma ras viral oncogene homolog) coactivation in the mouse liver promotes rapid carcinogenesis by way of mTOR (mammalian target of rapamycin complex 1), FOXM1 (forkhead box M1)/SKP2, and c-Myc pathwaysHepatology, 2011
- Modeling Hepatitis B Virus X–Induced Hepatocellular Carcinoma in Mice With the Sleeping Beauty Transposon System ΔHepatology, 2010
- Duration of Expression and Activity of Sleeping Beauty Transposase in mouse liver following hydrodynamic DNA deliveryMolecular Therapy, 2010
- Cancer gene discovery in hepatocellular carcinomaJournal of Hepatology, 2010
- Molecular targeted therapies in hepatocellular carcinoma†Hepatology, 2008
- Experimental models of hepatocellular carcinomaJournal of Hepatology, 2008
- The role of NF-κB in hepatocarcinogenesis: Promoter or suppressor?Journal of Hepatology, 2007
- Prolonged expression of a lysosomal enzyme in mouse liver after Sleeping Beauty transposon‐mediated gene delivery: implications for non‐viral gene therapy of mucopolysaccharidosesThe Journal of Gene Medicine, 2007
- Mutations in the p53 gene occur in diverse human tumour typesNature, 1989